NCT06001814

Brief Summary

Older people with HIV (OPWH) are disproportionately impacted by cardiovascular disease (CVD) attributable to behavioral risk factors, and chronic HIV immune dysregulation resulting inflammation. Systemic inflammation is exacerbated by psychological distress via activating the immune response and driving pro-inflammatory CVD risk behaviors. There is promising evidence to suggest that mindfulness could be an effective intervention to reduce psychological distress and support behaviorally- and inflammatory-mediated CVD risk reduction. This project aims to refine and synthesize mindfulness and behavior change content from evidence-based protocols (mindfulness-based stress reduction and diabetes prevention program) to develop and pilot test a new text message-enhanced intervention called "One Mind One Heart" (OM-OH) using feedback from semi-structured interviews with OPWH in psychological distress (N=20), and my multidisciplinary mentorship team (Aim 1). An open pilot (N=5) with exit interviews and pre-post self-report assessments, will inform the initial acceptability of OM-OH and further refine OM-OH as needed (Aim 2). Finally, a pilot randomized controlled trial (RCT; N=50) will be conducted to a.) evaluate benchmarks of feasibility and acceptability of study methods and refined OM-OH compared to enhanced usual care, and b.) investigate potential for effects on psychological distress, inflammation, and behavioral CVD risk (Aim 3). Findings will provide the foundation for an R01 application to conduct an efficacy trial of OM-OH to reduce inflammatory-mediated CVD risk among OPWH.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at below P25 for not_applicable hiv

Timeline
27mo left

Started Jul 2025

Typical duration for not_applicable hiv

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress29%
Jul 2025Aug 2028

First Submitted

Initial submission to the registry

August 3, 2023

Completed
18 days until next milestone

First Posted

Study publicly available on registry

August 21, 2023

Completed
1.9 years until next milestone

Study Start

First participant enrolled

July 21, 2025

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2028

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2028

Last Updated

September 22, 2025

Status Verified

September 1, 2025

Enrollment Period

2.9 years

First QC Date

August 3, 2023

Last Update Submit

September 17, 2025

Conditions

Outcome Measures

Primary Outcomes (9)

  • Feasibility of recruitment

    70% or more of participants consent to screening, meet screening criteria, are eligible, and agree to participate in the study

    Baseline (pre-intervention)

  • Feasibility of eligibility criteria

    Less than 20% of participants are ineligible due to each criterion

    Baseline (pre-intervention)

  • Feasibility of randomization

    70% or more of participants are randomized and complete the first intervention session

    Pre-intervention

  • Feasibility of the OM-OM intervention

    70% or more of participants attend all sessions and complete all homework

    Duration of intervention

  • Feasibility of research assessments

    70% or more of weekly and follow-up research assessments are completed

    Duration of intervention; 0 and 12-week follow-up

  • Feasibility of blood draws

    70% of more are collected

    Baseline; 12-week follow-up

  • Acceptability of OM-OH intervention

    Rating of 7.5 or greater/10 on: session satisfaction, helpfulness, and utility; overall program satisfaction; plan to use the skills; and would recommend the intervention program to a friend

    0-weeks post-intervention

  • Acceptability of text-enhanced delivery

    Rating of 7.5 or greater/10 on: ease, and confidence of use; and rating of 2 or less/10 on interference of technical problems

    0-weeks post-intervention

  • Acceptability of blood draws

    Rating of 7.5 or greater/10 on ease of collection; and rating of 2 or less/10 on pain

    0- and 12-weeks post-intervention

Secondary Outcomes (10)

  • Five Factor Mindfulness Questionnaire (FFMQ)

    0 and 12-weeks post-intervention

  • Patient Health Questionnaire - 9 (PHQ-9)

    0 and 12-weeks post-intervention

  • Generalized Anxiety Disorder - 7 (GAD-7)

    0 and 12-weeks post-intervention

  • Perceived Stress Scale (PSS)

    0 and 12-weeks post-intervention

  • HIV/AIDS Stress Scale

    0 and 12-weeks post-intervention

  • +5 more secondary outcomes

Study Arms (2)

One-Mind One-Heart

EXPERIMENTAL

One-Mind One-Heart (OM-OH) is intended to be a mindfulness-based, behavior change intervention to reduce psychological and behavioral cardiovascular disease risk.

Behavioral: One-Mind One-Heart

Education

ACTIVE COMPARATOR

The education session will provide information on behaviors important for cardiovascular disease risk reduction.

Other: Education

Interventions

One-Mind One-Heart will include mindfulness and behavior change skills to address psychological distress, physical activity, diet, and substance use.

One-Mind One-Heart

Education will be provided on behavioral cardiovascular disease risk reduction strategies, such as increasing physical activity, reducing salt intake in diet, and reduce/stop alcohol and tobacco-use.

Education

Eligibility Criteria

Age50 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age ≥50 years
  • clinical diagnosis of HIV per medical record or provision of current antiretroviral medication prescription
  • viral suppression - i.e., lower than detectable limit - per medical record or provision of viral load test from the past six months
  • current elevated psychological distress (score ≥10 on 10-item Kessler Psychological Distress Scale \[K10\]) screener)
  • ≥1 CVD risk factor (based on ACC/AHA Atherosclerotic Cardiovascular Disease Risk Score Calculator; e.g., diabetes, current smoker, hypertension, and high cholesterol
  • access to cell phone with text messaging capabilities

You may not qualify if:

  • non-English-speaking
  • cognitive impairments preventing informed consent
  • untreated or under-treated serious mental illness (i.e., psychosis and bipolar disorder) based on clinical interview

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Massachusetts General Hospital

Boston, Massachusetts, 02114, United States

RECRUITING

MeSH Terms

Conditions

Acquired Immunodeficiency SyndromeCardiovascular Diseases

Interventions

Educational Status

Condition Hierarchy (Ancestors)

HIV InfectionsBlood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesSlow Virus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System Diseases

Intervention Hierarchy (Ancestors)

Socioeconomic FactorsPopulation Characteristics

Central Study Contacts

Jacklyn Foley, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Psychologist

Study Record Dates

First Submitted

August 3, 2023

First Posted

August 21, 2023

Study Start

July 21, 2025

Primary Completion (Estimated)

June 30, 2028

Study Completion (Estimated)

August 31, 2028

Last Updated

September 22, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

We plan to share aggregated data only.

Locations